EUVIMEDEUVIMED entdecken
Fallbericht

Clinical Characteristics of Children with THRA Mutations: Variable Phenotype and Good Response to Recombinant Human Growth Hormone Therapy

Alexander Augusto de Lima Jorge, Nathalia L M Andrade, Raissa C Rezende, Lindiane G Crisostomo, Naiara C B Dantas, Laurana P Cellin, Vinicius de Souza, Elisangela P S Quedas, Antonio M Lerario, Gabriela A Vasques, Alexander A L Jorge

Hormone Research in Paediatrics · 2024

DOI: 10.1159/000539348 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Alexander Augusto de Lima Jorge und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unidade de Endocrinologia Genética (LIM 25), Hospital Das Clínicas da Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, Brazil. Hauptthemen laut MEDLINE: Human Growth Hormone, Mutation, Growth Disorders, Thyroid Hormone Resistance Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mutations in the thyroid hormone receptor alpha (THRA) gene are a rare cause of thyroid hormone resistance, which leads to a pleomorphic phenotypic spectrum. Hormonal profiles are variable and subtle, making laboratory diagnoses challenging. Genetic evaluation can be a helpful tool in diagnosing these cases. Case Presentation: Three patients (P1, P2, and P3) from unrelated families presented to their endocrinologists with short stature and abnormalities in thyroid function results. P1 showed hypoactivity and mild thyroid-stimulating hormone (TSH) elevation. P2 presented with a mild developmental delay and a hormonal profile initially interpreted as central hypothyroidism. Patient P3 had severe symptoms, including hypotonia, developmental delay, normal TSH, hypercholesterolemia, severe hypertriglyceridemia, high amylase levels, and mild pericardial effusion. All the patients had low free thyroxine (FT4) levels, mild constipation, and short stature. The patients underwent exome sequencing analysis that identified three different heterozygous variants in the THRA gene (P1 and P2 had missense variants, and P3 had a stop codon variant). All patients were treated with levothyroxine replacement, improving their clinical symptoms, such as constipation, and neurological symptoms. P1 and P2 were also treated with the recombinant human growth hormone (rhGH). The improvements in growth velocity and height standard deviation scores (SDS) were remarkable. Notably, P1 had a total height gain of 2.5 SDS, reaching an adult height within the normal range.

Conclusion

THRA gene defects can lead to growth disorders with different phenotypes. Children with THRA mutations can benefit from adequate treatment with levothyroxine and may respond well to rhGH treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Growth HormoneMutationGrowth DisordersThyroid Hormone Resistance SyndromeHumansMaleFemaleChildPhenotypeChild, PreschoolThyroxineRecombinant ProteinsAdolescent

Stichwörter der Autor:innen

Resistance to thyroid hormoneShort statureThyroid hormone receptor alpha 1

Substanzen

Human Growth HormoneThyroxineRecombinant Proteins

Autor:innen und Institutionen

  • Unidade de Endocrinologia Genética (LIM 25), Hospital Das Clínicas da Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, Brazil.
  • Departamento de Pediatria, Faculdade de Medicina do Centro Universitário São Camilo, São Paulo, Brazil.
  • Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular (LIM42), Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, Brazil.

Zitieren

APA

Jorge, A. A. L., Andrade, N. L. M., Rezende, R. C., Crisostomo, L. G., Dantas, N. C. B., Cellin, L. P., de Souza, V., Quedas, E. P. S., Lerario, A. M., Vasques, G. A., & Jorge, A. A. L. (2024). Clinical Characteristics of Children with THRA Mutations: Variable Phenotype and Good Response to Recombinant Human Growth Hormone Therapy. Hormone Research in Paediatrics. https://doi.org/10.1159/000539348

Vancouver

Jorge AAL, Andrade NLM, Rezende RC, Crisostomo LG, Dantas NCB, Cellin LP, et al. Clinical Characteristics of Children with THRA Mutations: Variable Phenotype and Good Response to Recombinant Human Growth Hormone Therapy. Hormone Research in Paediatrics. 2024. doi:10.1159/000539348

BibTeX
@article{Jorge2024,
  author = {Jorge, Alexander Augusto de Lima and Andrade, Nathalia L M and Rezende, Raissa C and Crisostomo, Lindiane G and Dantas, Naiara C B and Cellin, Laurana P and de Souza, Vinicius and Quedas, Elisangela P S and Lerario, Antonio M and Vasques, Gabriela A and Jorge, Alexander A L},
  title = {Clinical Characteristics of Children with THRA Mutations: Variable Phenotype and Good Response to Recombinant Human Growth Hormone Therapy},
  journal = {Hormone Research in Paediatrics},
  year = {2024},
  doi = {10.1159/000539348}
}
Kostenlos starten →